These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1126 related articles for article (PubMed ID: 34108465)

  • 21. Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia.
    Grant RA; Morales-Nebreda L; Markov NS; Swaminathan S; Querrey M; Guzman ER; Abbott DA; Donnelly HK; Donayre A; Goldberg IA; Klug ZM; Borkowski N; Lu Z; Kihshen H; Politanska Y; Sichizya L; Kang M; Shilatifard A; Qi C; Lomasney JW; Argento AC; Kruser JM; Malsin ES; Pickens CO; Smith SB; Walter JM; Pawlowski AE; Schneider D; Nannapaneni P; Abdala-Valencia H; Bharat A; Gottardi CJ; Budinger GRS; Misharin AV; Singer BD; Wunderink RG;
    Nature; 2021 Feb; 590(7847):635-641. PubMed ID: 33429418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alterations in lymphocyte subsets and monocytes in patients diagnosed with SARS-CoV-2 pneumonia: a mini review of the literature.
    Lagadinou M; Zareifopoulos N; Gkentzi D; Sampsonas F; Kostopoulou E; Marangos M; Solomou E
    Eur Rev Med Pharmacol Sci; 2021 Aug; 25(15):5057-5062. PubMed ID: 34355378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel insight from the first lung transplant of a COVID-19 patient.
    Chen XJ; Li K; Xu L; Yu YJ; Wu B; He YL; Zhao WE; Li D; Luan CX; Hu L; Wang J; Ding JJ; Yu YF; Li JX; Tan ZM; Liu XF; Wei D; Zhang ZH; Guo XJ; Su C; Hu ZB; Guo YS; Chen JY; Chen F
    Eur J Clin Invest; 2021 Jan; 51(1):e13443. PubMed ID: 33131070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating CD56dim natural killer cells and CD56+ T cells that produce interferon-γ or interleukin-10 are expanded in asymptomatic, E antigen-negative patients with persistent hepatitis B virus infection.
    Conroy MJ; Mac Nicholas R; Grealy R; Taylor M; Otegbayo JA; O'Dea S; Mulcahy F; Ryan T; Norris S; Doherty DG
    J Viral Hepat; 2015 Mar; 22(3):335-45. PubMed ID: 25186004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proinflammatory cytokines are associated with prolonged viral RNA shedding in COVID-19 patients.
    Gao C; Zhu L; Jin CC; Tong YX; Xiao AT; Zhang S
    Clin Immunol; 2020 Dec; 221():108611. PubMed ID: 33068796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status.
    Neidleman J; Luo X; McGregor M; Xie G; Murray V; Greene WC; Lee SA; Roan NR
    Elife; 2021 Oct; 10():. PubMed ID: 34636722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrated analysis of circulating immune cellular and soluble mediators reveals specific COVID19 signatures at hospital admission with utility for prediction of clinical outcomes.
    Uranga-Murillo I; Morte E; Hidalgo S; Pesini C; García-Mulero S; Sierra JL; Santiago L; Arias M; De Miguel D; Encabo-Berzosa MDM; Gracia-Tello B; Sanz-Pamplona R; Martinez-Lostao L; Galvez EM; Paño-Pardo JR; Ramirez-Labrada A; Pardo J
    Theranostics; 2022; 12(1):290-306. PubMed ID: 34987646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct Expression Patterns of Interleukin-22 Receptor 1 on Blood Hematopoietic Cells in SARS-CoV-2 Infection.
    Albayrak N; Orte Cano C; Karimi S; Dogahe D; Van Praet A; Godefroid A; Del Marmol V; Grimaldi D; Bondue B; Van Vooren JP; Mascart F; Corbière V
    Front Immunol; 2022; 13():769839. PubMed ID: 35422799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sex differences in immune responses that underlie COVID-19 disease outcomes.
    Takahashi T; Ellingson MK; Wong P; Israelow B; Lucas C; Klein J; Silva J; Mao T; Oh JE; Tokuyama M; Lu P; Venkataraman A; Park A; Liu F; Meir A; Sun J; Wang EY; Casanovas-Massana A; Wyllie AL; Vogels CBF; Earnest R; Lapidus S; Ott IM; Moore AJ; ; Shaw A; Fournier JB; Odio CD; Farhadian S; Dela Cruz C; Grubaugh ND; Schulz WL; Ring AM; Ko AI; Omer SB; Iwasaki A
    Nature; 2020 Dec; 588(7837):315-320. PubMed ID: 32846427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A systematic meta-analysis of immune signatures in patients with COVID-19.
    Liu K; Yang T; Peng XF; Lv SM; Ye XL; Zhao TS; Li JC; Shao ZJ; Lu QB; Li JY; Liu W
    Rev Med Virol; 2021 Jul; 31(4):e2195. PubMed ID: 34260780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased Blood Monocytic Myeloid Derived Suppressor Cells but Low Regulatory T Lymphocytes in Patients with Mild COVID-19.
    Jiménez-Cortegana C; Liró J; Palazón-Carrión N; Salamanca E; Sojo-Dorado J; de la Cruz-Merino L; Pascual Á; Rodríguez-Baño J; Sánchez-Margalet V
    Viral Immunol; 2021 Nov; 34(9):639-645. PubMed ID: 34529510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of T Lymphocyte Subsets and Natural Killer Lymphocytes in Moderate Versus Severe COVID-19 Patients.
    Gabr H; Abdel Aal AA; Bastawy S; Fateen M; Abd El Dayem OY; Youssef EA; Afifi R; Kamal M
    Viral Immunol; 2023 May; 36(4):250-258. PubMed ID: 36847755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disease-duration based comparison of subsets of immune cells in SARS CoV-2 infected patients presenting with mild or severe symptoms identifies prognostic markers for severity.
    Kulkarni-Munje A; Palkar S; Shrivastava S; Lalwani S; Mishra AC; Arankalle VA
    Immun Inflamm Dis; 2021 Jun; 9(2):419-434. PubMed ID: 33452858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biomarkers and Immune Repertoire Metrics Identified by Peripheral Blood Transcriptomic Sequencing Reveal the Pathogenesis of COVID-19.
    Liu Y; Wu Y; Liu B; Zhang Y; San D; Chen Y; Zhou Y; Yu L; Zeng H; Zhou Y; Zhou F; Yang H; Yin L; Huang Y
    Front Immunol; 2021; 12():677025. PubMed ID: 34504487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunological Characteristics in Type 2 Diabetes Mellitus Among COVID-19 Patients.
    Han M; Ma K; Wang X; Yan W; Wang H; You J; Wang Q; Chen H; Guo W; Chen T; Ning Q; Luo X
    Front Endocrinol (Lausanne); 2021; 12():596518. PubMed ID: 33776910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe COVID-19 patients display hyper-activated NK cells and NK cell-platelet aggregates.
    Malengier-Devlies B; Filtjens J; Ahmadzadeh K; Boeckx B; Vandenhaute J; De Visscher A; Bernaerts E; Mitera T; Jacobs C; Vanderbeke L; Van Mol P; Van Herck Y; Hermans G; Meersseman P; Wilmer A; Gouwy M; Garg AD; Humblet-Baron S; De Smet F; Martinod K; Wauters E; Proost P; Wouters C; Leclercq G; Lambrechts D; Wauters J; Matthys P
    Front Immunol; 2022; 13():861251. PubMed ID: 36275702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heightened Circulating Interferon-Inducible Chemokines, and Activated Pro-Cytolytic Th1-Cell Phenotype Features Covid-19 Aggravation in the Second Week of Illness.
    Tincati C; Cannizzo ES; Giacomelli M; Badolato R; d'Arminio Monforte A; Marchetti G
    Front Immunol; 2020; 11():580987. PubMed ID: 33193384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2 attachment to host cells is possibly mediated via RGD-integrin interaction in a calcium-dependent manner and suggests pulmonary EDTA chelation therapy as a novel treatment for COVID 19.
    Dakal TC
    Immunobiology; 2021 Jan; 226(1):152021. PubMed ID: 33232865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients.
    Notarbartolo S; Ranzani V; Bandera A; Gruarin P; Bevilacqua V; Putignano AR; Gobbini A; Galeota E; Manara C; Bombaci M; Pesce E; Zagato E; Favalli A; Sarnicola ML; Curti S; Crosti M; Martinovic M; Fabbris T; Marini F; Donnici L; Lorenzo M; Mancino M; Ungaro R; Lombardi A; Mangioni D; Muscatello A; Aliberti S; Blasi F; De Feo T; Prati D; Manganaro L; Granucci F; Lanzavecchia A; De Francesco R; Gori A; Grifantini R; Abrignani S
    Sci Immunol; 2021 Aug; 6(62):. PubMed ID: 34376481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two-Step In Vitro Model to Evaluate the Cellular Immune Response to SARS-CoV-2.
    Melgaço JG; Azamor T; Silva AMV; Linhares JHR; Dos Santos TP; Mendes YS; de Lima SMB; Fernandes CB; da Silva J; de Souza AF; Tubarão LN; Brito E Cunha D; Pereira TBS; Menezes CEL; Miranda MD; Matos AR; Caetano BC; Martins JSCC; Calvo TL; Rodrigues NF; Sacramento CQ; Siqueira MM; Moraes MO; Missailidis S; Neves PCC; Ano Bom APD
    Cells; 2021 Aug; 10(9):. PubMed ID: 34571855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.